Navigation Links
Hospira Reports Third-Quarter 2007 Results
Date:11/8/2007

n/a n/a

Net Income $60.7 $190.3 (68.1%) $250.6 $244.0 2.7%

Diluted EPS $0.38 $1.18 (67.8%) $1.57 $1.51 4.0%

Results under GAAP include the effects of the write-off of acquired in-process R&D relating to the Mayne Pharma acquisition, purchase accounting charges and amortization of intangibles resulting from the Mayne Pharma acquisition, and the Mayne Pharma integration charges in 2007; charges related to Hospira's manufacturing optimization initiatives in 2007 and 2006; and other items as detailed in the schedules attached to this press release.

Cash Flow

Cash flow from operations for the first nine months of 2007 was $354.5 million, up from $331.9 million in 2006.

Capital expenditures were $128.7 million for the first nine months of 2007, compared to $183.6 million for the same period in 2006. The decline is due to lower expenditures in 2007 related to the company's manufacturing optimization initiatives and to information technology as the company completed the build-out of its independent system in 2006.

2007 Projections

Hospira continues to project that adjusted* diluted earnings per share for 2007 will be in the range of $2.11 to $2.16. The reconciliation between the projected adjusted* diluted earnings per share and GAAP earnings per share is:

Diluted earnings per share -- adjusted* $2.11 - $2.16

--------------

Estimated charges related to previously announced

manufacturing optimization initiatives (mid-point

of an estimated range of $0.13 to $0.17 per diluted

share for 2007) ($0.15)

Estimated integration and other acquisition-related

expenses (mid-point of an estimated range of $0.18

to $0.22 per diluted share for 2007) ($0.20)

Estimated purchase
'/>"/>

SOURCE Hospira, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine news :

1. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
2. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... Healthpointe is proud to ... Alupay, an anesthesiologist and pain management specialist, will be evaluating and treating patients with ... conditions. , After receiving his Bachelor of Science in Biology from the University of ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... FSAstore.com ... convenient online destination for HSA holders. HSAstore.com makes it simple to use, spend and ... help consumers better understand their accounts. , According to a report by ...
(Date:7/7/2015)... NH (PRWEB) , ... July ... ... integrated, full-service public relations, marketing, and creative design firm, today announced that ... regional public relations and social media campaign, content strategy, and marketing launch ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... (NIWH) have jointly announced a partnership focused on providing knowledge organizing and ... studies. The study will be conducted with NIWH trained patient health educators, utilizing ...
(Date:7/7/2015)... ... July 07, 2015 , ... Nationally-renowned ... of their new website, the Invokana Ketoacidosis Lawsuit Center . The website ... as a resource for persons wishing to learn more about Invokana lawsuits for ...
Breaking Medicine News(10 mins):Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 3Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3
... a specific marker in the blood and tissues of certain ... they can be infected// for years with SIV, the primate ... published by Tulane University pathologist Ivona Pandrea in the scientific ... and intestines of five primate species that do not develop ...
... Rajasthan need not despair about becoming doctors. Rajasthan Medical University// ... move that is being questioned by many. ... number of failures in MBBS and to help those students ... ,As many as 25 students from Jaipur's SMS ...
... have doomsday predictions for the country’s health scenario unless drastic ... According to statistics released by the health ministry of Malaysia, ... HIV infected person by 2015. ,Of a population ... virus. , The figures show an increase of ...
... pregnant women are to be monitored more carefully according ... Francisco, as they are at a higher risk of giving ... , Mert Ozan Bahtiyar of Yale School of Medicine, who ... subjects, led the study. ,It was seen that ...
... According to a latest study sleep deprivation could affect the ... group of researchers// from Princeton University. They conducted this study ... rats – one group whose sleep was deprived for 72 ... indicated that lack of sleep in the first group affected ...
... case at United World College in the northeastern New Mexico ... the disease. ,Officials at the college near Las ... hospitalized with an infectious form of the disease. ... the lungs and other parts of the body. It is ...
Cached Medicine News:Health News:Tuberculosis Case Alarms Health Officials 2
(Date:7/7/2015)... , July 7, 2015   Decision Resources ... differences in dialysis patient management in the U.S. ... submitted by U.S. and EU5 nephrologists from approximately ... binders are the most commonly used renal medications ... iron differs considerably between the two regions.      ...
(Date:7/7/2015)...   InspireMD, Inc. (NYSE MKT: NSPR) ... protection systems ("EPS"), today announced that its MGuard ... MicroNet ™ has received the Frost & ... Award.  Through active market research efforts, Frost & ... the successful introduction of new and innovative products, ...
(Date:7/7/2015)... 2015 Oasmia Pharmaceutical AB, ... within human and veterinary oncology, today announced that ... the United States , designed to ... animal therapeutic.      (Logo: http://photos.prnewswire.com/prnh/20150420/740096) , ... , Paccal Vet-CA1 was previously distributed ...
Breaking Medicine Technology:Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5Oasmia Pharmaceutical Launches US Brand and Sales Platform 2
... April 29, 2011 Centocor Ortho Biotech Products, L.P., ... Drug Application (NDA) for trabectedin for the treatment of ... based on the U.S. Food and Drug Administration,s (FDA) ... to obtain approval. The NDA was submitted ...
... Phil Hagerman, president and CEO of Diplomat Specialty Pharmacy ... of the Year. The award was announced at ... annual award along with Grant Thornton LLP, WWJ Newsradio 950 ... Hagerman was chosen from among 45 nominees profiled during the ...
Cached Medicine Technology:Centocor Ortho Biotech Products, L.P. Voluntarily Withdraws NDA for Trabectedin 2Diplomat Specialty Pharmacy's Hagerman Named Grant Thornton Leader & Innovator of the Year 2Diplomat Specialty Pharmacy's Hagerman Named Grant Thornton Leader & Innovator of the Year 3